Your trusted destination for CME, CPD & Medical Education across the Middle East.
OTO HNS 2026 is a one-day CME-accredited summit covering advances in otolaryngology, head and neck surgery, and thyroid cancer care. The programme features expert lectures, case-based discussions, and interactive sessions focused on evidence-based clinical practice.
OTO HNS 2026 – Otolaryngology Head & Neck Summit and Thyroid Cancer Update is a one-day CME-accredited conference bringing together otolaryngologists, head and neck surgeons, researchers, and allied healthcare professionals to discuss current advances in otolaryngology and head and neck care. The programme provides a comprehensive review of contemporary diagnostic and treatment approaches, surgical innovations, emerging technologies, thyroid cancer management, and multidisciplinary care. The conference features keynote lectures, expert panel discussions, case-based sessions, and interactive educational forums designed to facilitate scientific exchange and practical learning. Participants will have opportunities to explore evidence-based approaches to complex clinical conditions, discuss evolving surgical and medical practices, and gain insights from experienced faculty. The programme emphasizes the application of updated knowledge to clinical practice, with sessions addressing current developments and emerging approaches in the management of otolaryngologic and head and neck conditions. Through expert-led discussions and case-based learning, the conference supports continuing professional development and encourages the exchange of clinical experiences and perspectives. The event is intended for otolaryngologists, head and neck surgeons, laryngologists, general surgeons, plastic and facial plastic surgeons, specialized nurses, and other healthcare professionals involved in the care of patients with ear, nose, throat, head and neck, and thyroid conditions. By bringing together professionals from related specialties, OTO HNS 2026 provides opportunities for multidisciplinary learning, professional networking, and collaboration. The activity is accredited for a **maximum of 5.25 AMA PRA Category 1 Credits™** through Cleveland Clinic Abu Dhabi, an institution accredited by the Accreditation Council for Continuing Medical Education (ACCME). Participants can use the programme to strengthen their understanding of current evidence-based practices, emerging technologies, and advances in head and neck surgery and thyroid cancer care while gaining practical knowledge applicable to clinical practice.
Exploring the latest surgical and medical treatments for head and neck cancers.
Innovative approaches to complex reconstructive procedures in the head and neck region.
Reviewing the latest evidence-based protocols for diagnosing and treating thyroid malignancies.
Technological advancements and minimally invasive techniques in thyroid surgery.
Integration of new diagnostic and therapeutic technologies into daily clinical practice.
Best practices for the medical management of common and complex otolaryngologic conditions.
Contemporary techniques balancing functional outcomes with aesthetic goals.
Multidisciplinary approaches to managing and reconstructing facial trauma.
Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designated for a maximum of 5.25 AMA PRA Category 1 Credits™.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
